We are live on
!
Find out more
RC
Reik & Co Portfolio holdings
AUM
$363M
1-Year Est. Return
3.03%
This Fund
S&P 500
This Quarter
Est. Return
+0.37%
1 Year Est. Return
-3.03%
3 Year Est. Return
+37.56%
5 Year Est. Return
+43.72%
10 Year Est. Return
+198.94%
AUM
$416M
AUM Growth
-$4.35M
(-1%)
Cap. Flow
-$2.43M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
87.52%
Holding
57
New
1
Increased
5
Reduced
17
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$222K |
| 2 |
Pfizer
PFE
|
+$203K |
| 3 |
Verizon
VZ
|
+$42.2K |
| 4 |
NVIDIA
NVDA
|
+$5.51K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Church & Dwight Co
CHD
|
+$909K |
| 2 |
Starbucks
SBUX
|
+$336K |
| 3 |
Moderna
MRNA
|
+$327K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$292K |
| 5 |
Procter & Gamble
PG
|
+$275K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 45.01% |
| 2 | Financials | 15.94% |
| 3 | Industrials | 11.15% |
| 4 | Consumer Discretionary | 11.01% |
| 5 | Technology | 3.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Fastenal
FAST
$54B
| $834K | 0.2% |
23,200
| – | – |
|
|
27
NVIDIA
NVDA
$5.01T
| $819K | 0.2% |
6,100
+40
| +0.7% | +$5.51K |
|
28
AbbVie
ABBV
$458B
| $800K | 0.19% |
4,500
| – | – |
|
29
Tejon Ranch
TRC
$476M
| $745K | 0.18% |
46,879
| – | – |
|
30
Colgate-Palmolive
CL
$72.6B
| $738K | 0.18% |
8,115
-905
| -10% | -$86.4K |
|
31
IBM
IBM
$202B
| $675K | 0.16% |
3,072
| – | – |
|
32
JPMorgan Chase
JPM
$939B
| $655K | 0.16% |
2,732
| – | – |
|
33
PepsiCo
PEP
$186B
| $655K | 0.16% |
4,305
| – | – |
|
|
DAI
34
DELISTED
DAIMLER AG
DAI
| $605K | 0.15% |
10,955
| – | – |
|
35
Analog Devices
ADI
$181B
| $583K | 0.14% |
2,745
| – | – |
|
36
Abbott
ABT
$180B
| $522K | 0.13% |
4,613
| – | – |
|
|
37
Verizon
VZ
$194B
| $498K | 0.12% |
12,463
+1,000
| +9% | +$42.2K |
|
38
Tootsie Roll Industries
TR
$2.82B
| $487K | 0.12% |
15,982
| – | – |
|
39
Omega Healthcare
OHI
$15.4B
| $466K | 0.11% |
12,305
| – | – |
|
40
Blackstone
BX
$104B
| $418K | 0.1% |
2,425
| – | – |
|
|
K
41
DELISTED
Kellanova
K
| $341K | 0.08% |
4,210
| – | – |
|
42
Merck
MRK
$324B
| $290K | 0.07% |
2,914
| – | – |
|
43
Invesco Dorsey Wright Technology Momentum ETF
PTF
$632M
| $261K | 0.06% |
3,600
| – | – |
|
44
Walmart Inc
WMT
$871B
| $244K | 0.06% |
2,700
| – | – |
|
|
45
Morgan Stanley
MS
$337B
| $226K | 0.05% |
+1,800
| New | +$222K |
|
46
ExxonMobil
XOM
$651B
| $224K | 0.05% |
2,087
| – | – |
|
47
Ford
F
$57.3B
| $176K | 0.04% |
17,819
| – | – |
|
|
48
Moderna
MRNA
$21.5B
| – | – |
-4,898
| Closed | -$327K |
|
Similar funds
VIA
MS
WI
HS
SIAG
BHBT
WTFG
MA
Reik & Co's Q4 2024 Portfolio in Review
As of Q4 2024, Reik & Co held 57 positions worth $416M, down 1% from $420M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.5%. Reik & Co opened 1 new position and exited 1, leaving the 57-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Staples at 45% of assets, down from 46% a quarter earlier, followed by Financials and Industrials.
- Reik & Co's largest Q4 2024 buy was Morgan Stanley: 1,800 shares worth $226K.
- Reik & Co added most to Pfizer in Q4 2024, an estimated $203K increase.
- Reik & Co's biggest Q4 2024 reduction was Church & Dwight Co, cutting an estimated $909K.
- Reik & Co fully exited Moderna in Q4 2024, selling an estimated $327K.
- Reik & Co's ten largest holdings make up 88% of its $416M portfolio in Q4 2024.
- Reik & Co opened 1 new position and closed 1 in Q4 2024.
- Reik & Co's portfolio value fell 1% quarter-over-quarter to $416M.
Based on Reik & Co's 13F filing for Q4 2024, filed 29 Jan 2025.